Skip to Content

← See all Hyundai Moolpas F brands

Hyundai Moolpas F by Scott Holdings Co., Ltd.

Dosage form: solution
Ingredients: METHYL SALICYLATE 3g in 100mL
Labeler: Scott Holdings Co., Ltd.
NDC Code: 68994-1001

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Facts

methyl salicylate


camphor, menthol, chlorpherol acetate, glycyrrhetic acid


- antiinflammatory analgesic of the following symptoms:  sprain, contusion, myosalgia, backache, shoulder discomfort, neuralgia, rheumarthritis- pernio


keep out or reach of the children


apply to the affected area once to several times a day


avoid contact with eyes, if this product splashes in to your eyes, wash immediately with water


for external use only


HYUNDAI MOOLPAS F 
methyl salicylate solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68994-1001
Route of AdministrationTRANSDERMALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
METHYL SALICYLATE (SALICYLIC ACID) METHYL SALICYLATE3 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
MENTHOL 
CAMPHOR (SYNTHETIC) 
CHLORPHENIRAMINE MALEATE 
.ALPHA.-TOCOPHEROL ACETATE 
Packaging
#Item CodePackage Description
1NDC:68994-1001-188 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34805/16/2014
Labeler - Scott Holdings Co., Ltd. (689665651)
Registrant - Scott Holdings Co., Ltd. (689665651)
Establishment
NameAddressID/FEIOperations
Hyundai Pharmaceutical Co., Ltd.687874958manufacture(68994-1001)

 
Scott Holdings Co., Ltd.

← See all Hyundai Moolpas F brands

Medically reviewed on May 16, 2018

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide